These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18977267)

  • 21. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
    Pietrzyk JJ; Wysocki J; Pejcz J; Galaj A; Majda-Stanislawska E; Käyhty H; Thierry-Carstensen B; Jensen AM
    Vaccine; 2008 Sep; 26(41):5296-303. PubMed ID: 18675870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
    Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.
    Bults M; Kemmeren JM; van der Maas NA
    Vaccine; 2007 Jul; 25(29):5272-7. PubMed ID: 17573165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.
    Lee S; Park WB; Shin KH; Ahn DH; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Vaccine; 2011 Oct; 29(44):7638-43. PubMed ID: 21864613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated.
    Kerdpanich A; Warachit B; Kosuwon P; Gatchalian SR; Watanaveeradej V; Borkird T; Kosalaraksa P; Han HH; Hutagalung Y; Boutriau D; Dobbelaere K
    Int J Infect Dis; 2008 Jan; 12(1):88-97. PubMed ID: 17716936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid.
    Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M
    Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized double-blind controlled trial.
    Jansen AG; Sanders EA; Smulders S; Hoes AW; Hak E
    Pediatr Allergy Immunol; 2008 Sep; 19(6):552-8. PubMed ID: 18221474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.
    Miernyk KM; Butler JC; Bulkow LR; Singleton RJ; Hennessy TW; Dentinger CM; Peters HV; Knutsen B; Hickel J; Parkinson AJ
    Clin Infect Dis; 2009 Jul; 49(2):241-8. PubMed ID: 19522655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
    Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
    J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance of vaccine safety: comparison of parental reports with routine surveillance and a clinical trial.
    Netterlid E; Månsson ME; Håkansson A
    Vaccine; 2009 Mar; 27(14):2042-7. PubMed ID: 19428828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine.
    Center KJ; Hansen JR; Lewis E; Fireman BH; Hilton B
    Pediatr Infect Dis J; 2009 May; 28(5):438-40. PubMed ID: 19319016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.
    Jackson LA; Yu O; Nelson J; Belongia EA; Hambidge SJ; Baxter R; Naleway A; Nordin J; Baggs J; Iskander J
    Vaccine; 2009 Aug; 27(36):4912-6. PubMed ID: 19567245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar) since vaccine introduction.
    Center KJ; Strauss A
    Vaccine; 2009 May; 27(25-26):3281-4. PubMed ID: 19200818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine.
    Socan M; Frelih T; Janet E; Petras T; Peternelj B
    Vaccine; 2004 Aug; 22(23-24):3087-91. PubMed ID: 15297059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.
    Goldblatt D; Southern J; Andrews N; Ashton L; Burbidge P; Woodgate S; Pebody R; Miller E
    Clin Infect Dis; 2009 Nov; 49(9):1318-25. PubMed ID: 19814624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives.
    Bechini A; Boccalini S; Bonanni P
    Vaccine; 2009 May; 27(25-26):3285-90. PubMed ID: 19200829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.